CIK 0001624326 · Non-accelerated filer<br>Smaller reporting company
PAVmed Inc.
Sign in to watch- Ticker
- PAVM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471214177
- Phone
- (212) 949-4319
- Business address
- 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10017
- Former names
- PAXmed Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 50 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | Aklog Lishan Chairman and CEO | Grant or award | +150,000 | 1,255,913 | ||
| 2021-03-18 | Aklog Lishan Chairman and CEO | Purchase | +7,500 | $4.31 | $32K | 1,105,913 |
| 2020-11-25 | SIROVICH MATTHEW 10% owner | Sale | −33,203 | $1.96 | $65K | 1,027,744 |
| 2020-11-24 | SIROVICH MATTHEW 10% owner | Sale | −53,036 | $2.00 | $106K | 1,060,947 |
| 2020-11-19 | SIROVICH MATTHEW 10% owner | Sale | −75,211 | $1.83 | $137K | 1,113,983 |
| 2020-11-18 | SIROVICH MATTHEW 10% owner | Sale | −24,789 | $1.78 | $44K | 1,189,194 |
| 2020-05-29 | SIROVICH MATTHEW 10% owner | Sale | −131,082 | $1.98 | $259K | 1,213,983 |
| 2020-05-28 | SIROVICH MATTHEW 10% owner | Sale | −69,839 | $2.06 | $144K | 1,345,065 |
| 2020-04-30 | Weild IV David Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-04-30 | Sparks Ronald M Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-04-30 | Glennon Michael J Vice Chairman | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-04-30 | DeGuzman Brian J. Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-04-30 | Cox James L Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-04-30 | Battleman David S. Director | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-04-30 | Aklog Lishan Chairman and CEO | Grant or award | +250,000 | 1,098,413 | ||
| 2020-04-30 | MCGRATH DENNIS M President & CFO | Grant or award | +250,000 | 791,704 | ||
| 2020-01-30 | SIROVICH MATTHEW 10% owner | Option exercise | +1,199,383 | $0.01 | $12K | 1,938,297 |
| 2020-01-30 | SIROVICH MATTHEW 10% owner | Option exercise · Series S Warrants (right to buy) | −1,199,383 | 0 | ||
| 2019-05-24 | MCGRATH DENNIS M President & CFO | Purchase | +5,000 | $1.09 | $5K | 529,000 |
| 2019-05-23 | Aklog Lishan Chairman and CEO | Purchase | +30,000 | $1.10 | $33K | 848,413 |
Page 4 of 6 · 119 trades